232 related articles for article (PubMed ID: 17467326)
1. Craniofacial osteosarcoma Experience of the cooperative German-Austrian-Swiss osteosarcoma study group.
Jasnau S; Meyer U; Potratz J; Jundt G; Kevric M; Joos UK; Jürgens H; Bielack SS;
Oral Oncol; 2008 Mar; 44(3):286-94. PubMed ID: 17467326
[TBL] [Abstract][Full Text] [Related]
2. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).
Kempf-Bielack B; Bielack SS; Jürgens H; Branscheid D; Berdel WE; Exner GU; Göbel U; Helmke K; Jundt G; Kabisch H; Kevric M; Klingebiel T; Kotz R; Maas R; Schwarz R; Semik M; Treuner J; Zoubek A; Winkler K
J Clin Oncol; 2005 Jan; 23(3):559-68. PubMed ID: 15659502
[TBL] [Abstract][Full Text] [Related]
4. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.
Bacci G; Longhi A; Versari M; Mercuri M; Briccoli A; Picci P
Cancer; 2006 Mar; 106(5):1154-61. PubMed ID: 16421923
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of increased angiogenesis in osteosarcoma.
Kreuter M; Bieker R; Bielack SS; Auras T; Buerger H; Gosheger G; Jurgens H; Berdel WE; Mesters RM
Clin Cancer Res; 2004 Dec; 10(24):8531-7. PubMed ID: 15623635
[TBL] [Abstract][Full Text] [Related]
8. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.
Mialou V; Philip T; Kalifa C; Perol D; Gentet JC; Marec-Berard P; Pacquement H; Chastagner P; Defaschelles AS; Hartmann O
Cancer; 2005 Sep; 104(5):1100-9. PubMed ID: 16015627
[TBL] [Abstract][Full Text] [Related]
9. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
Nathan SS; Gorlick R; Bukata S; Chou A; Morris CD; Boland PJ; Huvos AG; Meyers PA; Healey JH
Cancer; 2006 Oct; 107(7):1607-16. PubMed ID: 16933325
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group.
Ozaki T; Flege S; Liljenqvist U; Hillmann A; Delling G; Salzer-Kuntschik M; Jürgens H; Kotz R; Winkelmann W; Bielack SS
Cancer; 2002 Feb; 94(4):1069-77. PubMed ID: 11920477
[TBL] [Abstract][Full Text] [Related]
11. Interdisciplinary combined treatment of craniofacial osteosarcoma with neoadjuvant and adjuvant chemotherapy and excision of the tumour: a retrospective study.
Thiele OC; Freier K; Bacon C; Egerer G; Hofele CM
Br J Oral Maxillofac Surg; 2008 Oct; 46(7):533-6. PubMed ID: 18436357
[TBL] [Abstract][Full Text] [Related]
12. Improved outcomes in patients with osteogenic sarcoma of the head and neck.
Patel SG; Meyers P; Huvos AG; Wolden S; Singh B; Shaha AR; Boyle JO; Pfister D; Shah JP; Kraus DH
Cancer; 2002 Oct; 95(7):1495-503. PubMed ID: 12237918
[TBL] [Abstract][Full Text] [Related]
13. Osteosarcoma: the COSS experience.
Bielack S; Jürgens H; Jundt G; Kevric M; Kühne T; Reichardt P; Zoubek A; Werner M; Winkelmann W; Kotz R
Cancer Treat Res; 2009; 152():289-308. PubMed ID: 20213397
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
[TBL] [Abstract][Full Text] [Related]
15. Free osseous and soft tissue surgical margins as prognostic factors in mandibular osteosarcoma.
Granados-Garcia M; Luna-Ortiz K; Castillo-Oliva HA; Villavicencio-Valencia V; Herrera-Gómez A; Mosqueda-Taylor A; Aguilar-Ponce JL; Poitevin-Chacón A
Oral Oncol; 2006 Feb; 42(2):172-6. PubMed ID: 16246617
[TBL] [Abstract][Full Text] [Related]
16. Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience.
Chou AJ; Merola PR; Wexler LH; Gorlick RG; Vyas YM; Healey JH; LaQuaglia MP; Huvos AG; Meyers PA
Cancer; 2005 Nov; 104(10):2214-21. PubMed ID: 16206297
[TBL] [Abstract][Full Text] [Related]
17. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
[TBL] [Abstract][Full Text] [Related]
18. Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group.
Kager L; Zoubek A; Kastner U; Kempf-Bielack B; Potratz J; Kotz R; Exner GU; Franzius C; Lang S; Maas R; Jürgens H; Gadner H; Bielack S;
J Clin Oncol; 2006 Apr; 24(10):1535-41. PubMed ID: 16575004
[TBL] [Abstract][Full Text] [Related]
19. Post operative infection and increased survival in osteosarcoma patients: are they associated?
Jeys LM; Grimer RJ; Carter SR; Tillman RM; Abudu A
Ann Surg Oncol; 2007 Oct; 14(10):2887-95. PubMed ID: 17653803
[TBL] [Abstract][Full Text] [Related]
20. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients.
Bielack SS; Kempf-Bielack B; Branscheid D; Carrle D; Friedel G; Helmke K; Kevric M; Jundt G; Kühne T; Maas R; Schwarz R; Zoubek A; Jürgens H
J Clin Oncol; 2009 Feb; 27(4):557-65. PubMed ID: 19075282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
